Equity benchmark indices staged a mild recovery on Tuesday after falling for four trading sessions, boosted by dip in retail ...

HCL Tech’s margin concerns and growth outlook trigged mixed ratings and target price cuts from brokerages leading brokerages ...

HCLTech on Monday cut its FY26 EBIT margin guidance to 17–18%, from 18–19% earlier, after operating margins declined sharply ...

HCLTech shares declined over 4 percent after a 9.7 percent drop in Q1 net profit. Higher expenses, a client bankruptcy, and ...

Reacting to Q1 results, HCL Tech shares dropped as much as 3.3% to ₹1,566 on the BSE, while its market capitalisation dropped ...

HCL Technologies share price declined by 2.01 per cent to Rs 1,587.20 in early trade on Tuesday, following the release of its ...

Shares of HCL Technologies will be in focus after the IT major reported weaker-than-expected June quarter results ...

Nirmal Bang noted that Q1 is usually a soft quarter for HCL Tech and some part of the sequential revenue decline can be attributed to its software business.

In the pre-market session, the benchmark BSE Sensex fell marginally by 7.6 points, or 0.01 per cent to 82,245.85 levels, ...

AstraZeneca Pharma India has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India to import for sale and ...

HCLTech’s muted Q1 and lower margin guidance have raised investor concerns. While revenue guidance has improved slightly, ...

Indian equity indices, Sensex and Nifty, are expected to open on flat-to-higher note on Tuesday following positive global ...